Networking +
Policy +
Member
Career
Choose
Date
Event
9
Feb
Life Sciences Dealmaking: Recent Trends and the Outlook for 2023
Thursday, Feb 9, 202312:00—1:00pm
This session will provide a review of life sciences dealmaking trends over the past volatile year, including deal points to watch and predictions for the 2023 M&A landscape in this fast-moving sector.
Speakers
Barbara Borden
Partner @Cooley
Barbara is co-chair of Cooley’s mergers & acquisitions practice. She focuses on public and private M&A, cross-border transactions, joint ventures and other complex transactions. Barbara represents strategic and financial buyers and sellers in public and private acquisitions, and has significant experience counseling boards of directors in connection with M&A and related governance, as well as anti-takeover matters.
.
Rama Padmanabhan
Partner @Cooley
Rama focuses her practice on all types of public and private M&A and cross-border transactions, with an emphasis on Asia. She has extensive experience with SPAC M&A transactions, reverse mergers, representation of financial buyers and sellers, joint ventures, navigating IPO/M&A dual-track processes, and other complex transactions. Her industry experience includes technology, fintech, software, semiconductor, digital health and retail. She is a market leader in life sciences, biotech and medical device transactions, with deep experience in divestitures, options to buy and structured transactions.
.
Register
11:00 am PT // 2:00 pm ET // 12 pm MST